Signs Point To Banner Year For Novel Approvals In 2014
This article was originally published in The Pink Sheet Daily
Executive Summary
With a month to go in 2014, FDA’s novel approval count has hit 43 – blowing past 2013’s full-year count of 35 new molecular entities and novel biologics from both CDER and CBER and within striking distance of 2012’s high of 45. Biologics are making the difference.